MedTrace Logo

Developing a Real-Time PCR Assay for Fusobacterium and Epidemiological Analysis of Tumor Patients

NCT06168513 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 490

Last updated 2024-04-19

No results posted yet for this study

Summary

This study presents an academic approach to developing a fluorescence quantitative PCR detection method capable of accurately measuring the presence of Fusobacterium (specifically F. nucleatum, F. mortiferium, F. varium, F. ulcerans, F. and F. necrogens) in human fecal samples. It aims to perform an epidemiological analysis on the presence of Fusobacterium in patients with tumors, elucidating the prevalence of Fusobacterium members in this patient population. Additionally, it seeks to investigate the potential correlation between Fusobacterium presence and various test indicators, diagnostic predictions, and prognosis outcomes.

Conditions

  • Fusobacterium Infections

Sponsors & Collaborators

  • National Natural Science Foundation of China

    collaborator OTHER_GOV

  • Zhujiang Hospital

    lead OTHER

Principal Investigators

  • Houwei Zhou, professor · Zhujiang Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06168513 on ClinicalTrials.gov